Our findings suggest a mechanism for the poor clinical outcomes associated with a desmoplastic TME as we hypothesize that the high expression of collagen-I seen in desmoplasia can increase the invasive capacity of breast cancer cells via its regulation of Annexin A2. This evidence concerns the gene ANXA2 and breast cancer.